TNF and non-small cell lung carcinoma: Considering current treatment guidelines, future research should aim to encompass immunotherapy data, both when administered post-chemoradiotherapy and concurrently, to thoroughly understand its influence on inflammatory processes and TNF-related responses in NSCLC patients.